Bespoke Extracts Faces Financial Challenges Despite Revenue Growth in Cannabis Market

Bespoke Extracts, Inc. (PINK: BSPK) is currently navigating various financial challenges while attempting to stabilize its operations in the regulated cannabis market in the United States. The latest income statement shows both positive growth in revenue along with continuing net losses, reflecting the company's ongoing struggles.

Income Statement Highlights (Q1 2025 vs. Q1 2024):

• Sales: Increased to $263,159 from $260,428, driven by higher sales of branded pre-rolled products.
• Cost of Goods Sold (COGS): Decreased to $152,380 from $157,847, indicating improved efficiencies in production with rising packaging and testing costs.
• Gross Profit: Rose to $110,779 from $102,581, benefiting from lower COGS relative to sales.
• Total Operating Expenses: Reduced to $356,117 from $405,384, reflecting lower selling, general administrative expenses and professional fees.
• Net Loss: Improved to $(260,521) or $(0.02) per share, compared to $(314,118) or $(0.03) per share in the same quarter last year.

Positive Aspects:

• Sales growth suggests increasing demand for the company's products, potentially indicative of a successful strategy in the evolving cannabis market.
• Improved gross profit and decreased operating expenses are signs of operational efficiencies being realized under new management.

Negative Aspects:

• Despite increased sales, the company continues to operate at a loss, indicating challenges in achieving profitability.
• Current liabilities are high, totaling $1,241,535, which includes significant accounts payable, raising concerns about liquidity.
• Accumulated deficit has increased to $(26,664,637), highlighting ongoing profitability issues and potential long-term sustainability risks.

Key Statistics:

• Cash at March 31, 2025: $30,365, down from $60,305 at the end of 2024.
• Operating cash flow for Q1 2025: $(72,940), an improvement over $(97,191) in Q1 2024.
• Total liabilities as of March 31, 2025: $2,582,325.
• Weighted average common shares outstanding: 11,153,220 shares.

The statement reflects Bespoke Extracts' efforts to stabilize its financial condition while addressing operational challenges and navigating a competitive market landscape. The ongoing net losses continue to raise questions about the long-term viability unless prompt actions are taken to enhance cash flow and profitability.